GlassScriptPhysician profile
Jessica Ueda
NPI 1679069090
$4,477.01
in general payments reported to CMS, 2019-2025
37 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,506 · 2022: $908 · 2023: $922 · 2024: $726 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,112.76 | 2021-2025 | |
| Novo Nordisk INC | $770.94 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $278.98 | 2021-2025 | Mounjaro |
| Glaxosmithkline, LLC. | $249.16 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $246.11 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $209.52 | 2021-2025 | |
| Astellas Pharma US INC | $165.96 | 2021-2024 | Veozah, Myrbetriq |
| Amgen INC. | $152.27 | 2021-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.17 | 2021-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $139.20 | 2021-2025 | |
| Exact Sciences Corporation | $77.00 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.24 | 2022-2024 | Xifaxan |
| Amarin Pharma, INC. | $73.96 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $72.54 | 2023 | |
| Paratek Pharmaceuticals, INC. | $64.47 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Ueda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.